Back to results
US 2011/0236429 A1Published application
Small Cationic Antimicrobial Peptides
AssigneeThe University of British Columbia
InventorsRobert E. W. Hancock, Kai Hilpert, Artem Cherkasov, Christopher Fjell
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
Claims20
-146. (canceled)
An isolated immunomodulatory peptide comprising an amino acid sequence of SEQ ID NO:
- 2 or a related peptide comprising an amino acid sequence of SEQ ID NO:
- 1213, 1214, 1222, 1224, 1230, 1232, 12, or 1238, or an amino acid sequence having 90% identity thereto.
A method for enhancing a vaccine-induced adaptive immune response in a subject comprising administering to the subject an adjuvant composition comprising a pharmaceutically acceptable carrier and a peptide of claim 1 in an amount effective to enhance the vaccine-induced adaptive immune response in the subject.
Dependencies are inferred from the claim text.